Economic Evaluations of HPV Vaccination in Targeted Regions of Low- and Middle-Income Countries: A Systematic Review of Modelling Studies

被引:6
作者
Frianto, Dedy [1 ,2 ]
Setiawan, Didik [3 ]
Diantini, Ajeng [1 ,4 ]
Suwantika, Auliya A. [1 ,4 ,5 ]
机构
[1] Univ Padjadjaran, Fac Pharm, Dept Pharmacol & Clin Pharm, Bandung, Indonesia
[2] Univ Buana Perjuangan, Fac Pharm, Karawang, Indonesia
[3] Univ Muhammadiyah Purwokerto, Fac Pharm, Purwokerto, Indonesia
[4] Univ Padjadjaran, Ctr Excellence Higher Educ Pharmaceut Care Innovat, Bandung, Indonesia
[5] Univ Padjadjaran, Fac Pharm, Jl Raya Bandung Sumedang Km 21, Jatinangor 45363, Sumedang, Indonesia
关键词
cost-effectiveness; cervical cancer; vaccine; immunization; screening; HUMAN-PAPILLOMAVIRUS VACCINATION; COST-EFFECTIVENESS; CERVICAL-CANCER; GIRLS;
D O I
10.2147/IJWH.S367953
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background: In countries with limited resources, a targeted HPV vaccination strategy by focusing in selected regions is preferable to be implemented than a nationwide vaccination strategy.Objective: This study aimed to review articles on economic evaluations of HPV vaccination in countries over the world that applied targeted vaccination strategies.Methods: Approximately 1769 articles were obtained from two databases (1242 and 527 articles from PubMed and ProQuest, respectively). The inclusion criteria in this systematic review were studies about full economic evaluations of HPV vaccination in targeted area or sub-national level and written in English. Full-text screening was applied to evaluate the eligibility. Final articles obtained were referred to the Consolidated Health Economic Evaluation Reporting Standard (CHEERS) checklist. Finally, we included only 4 articles that met all inclusion and exclusion criteria. Results: Included studies in this review focused in different targeted regions, such as Punjab State in India, Vientiane in Lao PDR, Southern Vietnam in Vietnam, and Brazilian Amazon in Brazil. From 24 criteria in the CHEERS checklist, all included studies could meet 21 criteria (87.5%). All included studies in this review applied modeling approaches, which can estimate the number of cases and treatment costs averted. Applying various settings, the results of this study showed that HPV vaccination could potentially reduce the number of cervical cancer cases by 20-72%. Taking cervical cancer screening into account, this study showed that targeted HPV vaccination was cost-effective or even cost-saving.Conclusion: Implementation of HPV vaccination in sub-national level as the initial step before nationwide vaccination is more favorable to be implemented in countries with limited budget.
引用
收藏
页码:1315 / 1322
页数:8
相关论文
共 21 条
[1]   Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis [J].
Arbyn, Marc ;
Weiderpass, Elisabete ;
Bruni, Laia ;
de Sanjose, Silvia ;
Saraiya, Mona ;
Ferlay, Jacques ;
Bray, Freddie .
LANCET GLOBAL HEALTH, 2020, 8 (02) :E191-E203
[2]   Setting healthcare priorities: a description and evaluation of the budgeting and planning process in county hospitals in Kenya [J].
Barasa, EdwineW. ;
Cleary, Susan ;
Molyneux, Sassy ;
English, Mike .
HEALTH POLICY AND PLANNING, 2017, 32 (03) :329-337
[3]   Economic Evaluation of Screening Strategies Combined with HPV Vaccination of Preadolescent Girls for the Prevention of Cervical Cancer in Vientiane, Lao PDR [J].
Chanthavilay, Phetsavanh ;
Reinharz, Daniel ;
Mayxay, Mayfong ;
Phongsavan, Keokedthong ;
Marsden, Donald E. ;
Moore, Lynne ;
White, Lisa J. .
PLOS ONE, 2016, 11 (09)
[4]  
da Fonseca AJ, 2013, REV ASSOC MED BRAS, V59, P442
[5]   Cervical cancer in low and middle-income countries [J].
Hull, Rodney ;
Mbele, Mzwandile ;
Makhafola, Tshepiso ;
Hicks, Chindo ;
Wang, Shao-Ming ;
Reis, Rui Manuel ;
Mehrotra, Ravi ;
Mkhize-Kwitshana, Zilungile ;
Kibiki, Gibson ;
Bates, David O. ;
Dlamini, Zodwa .
ONCOLOGY LETTERS, 2020, 20 (03) :2058-2074
[6]   Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement [J].
Husereau, Don ;
Drummond, Michael ;
Petrou, Stavros ;
Carswell, Chris ;
Moher, David ;
Greenberg, Dan ;
Augustovski, Federico ;
Briggs, Andrew H. ;
Mauskopf, Josephine ;
Loder, Elizabeth .
VALUE IN HEALTH, 2013, 16 (02) :E1-E5
[7]   Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling study [J].
Jit, Mark ;
Brisson, Marc ;
Portnoy, Allison ;
Hutubessy, Raymond .
LANCET GLOBAL HEALTH, 2014, 2 (07) :E406-E414
[8]   Effect of cervical cancer education and provider recommendation for screening on screening rates: A systematic review and meta-analysis [J].
Musa, Jonah ;
Achenbach, Chad J. ;
O'Dwyer, Linda C. ;
Evans, Charlesnika T. ;
McHugh, Megan ;
Hou, Lifang ;
Simon, Melissa A. ;
Murphy, Robert L. ;
Jordan, Neil .
PLOS ONE, 2017, 12 (09)
[9]   A randomized controlled trial of Human Papillomavirus (HPV) testing for cervical cancer screening: trial design and preliminary results (HPV FOCAL Trial) [J].
Ogilvie, Gina S. ;
van Niekerk, Dirk J. ;
Krajden, Mel ;
Martin, Ruth E. ;
Ehlen, Thomas G. ;
Ceballos, Kathy ;
Peacock, Stuart J. ;
Smith, Laurie W. ;
Kan, Lisa ;
Cook, Darrel A. ;
Mei, Wendy ;
Stuart, Gavin C. E. ;
Franco, Eduardo L. ;
Coldman, Andrew J. .
BMC CANCER, 2010, 10
[10]  
PAHO, STRAT HPV VACC DEV W